Page last updated: 2024-11-03

pseudohypericin and HIV

pseudohypericin has been researched along with HIV in 1 studies

pseudohypericin: structure given in first source

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, I1
Nakanishi, S1
Kobayashi, E1
Nakano, H1
Suzuki, K1
Tamaoki, T1

Other Studies

1 other study available for pseudohypericin and HIV

ArticleYear
Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity.
    Biochemical and biophysical research communications, 1989, Dec-29, Volume: 165, Issue:3

    Topics: Animals; Anthracenes; Antiviral Agents; Benz(a)Anthracenes; Brain; Calpain; Cattle; Cells, Cultured;

1989